Incannex Healthcare IXHL
NASDAQ IXHL
$3.36 -0.01 (-0.45%)
As of: Sep 9, 2026 · 12:59 PM EDT

Incannex Healthcare (IXHL) Other Operating Expenses (2024)

Incannex Healthcare's (IXHL) quarterly Other Operating Expenses came in at -$1.1 million in Q4 2024.

Analysis

Incannex Healthcare (IXHL) Other Operating Expenses (2024) Analysis & Trends

Incannex Healthcare has disclosed Other Operating Expenses across 1 years of filings, most recently posting -$1.1 million for Q4 2024.

  • In Q4 2024, Other Operating Expenses changed N/A year-over-year to -$1.1 million; the TTM figure through Sep 2025 stood at -$1.1 million (changed N/A YoY), while the FY2025 annual figure was -$932000.0, down 13.24% from the prior year.
  • Other Operating Expenses came in at -$1.1 million for Q4 2024 at Incannex Healthcare.
  • In the past five years, Other Operating Expenses ranged from a high of -$1.1 million in Q4 2024 to a low of -$1.1 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn
10 Incannex Healthcare 41.43 Mn 41.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.10 Mn